Acquired neuromyotonia (Isaac's syndrome) is considered excitability, also occur in various neurological disorders such as Guillain-Barré syndrome and idiopathic to be an autoimmune disease, and the pathomechanism of nerve hyperexcitability in this syndrome is correlated generalized myokymia without pseudomyotonia. Immunoglobulins from patients with these diseases suppressed with anti-voltage-gated K ⍣ channel (VGKC) antibodies. The patch-clamp technique was used to investigate the K ⍣ but not Na ⍣ currents. In addition, in hKv 1.1-and 1.6-transfected CHO (Chinese hamster ovary)-K1 cells, effects of immunoglobulins from acquired neuromyotonia patients on VGKCs and voltage-gated Na ⍣ channels in a the expressed VGKCs were suppressed by sera from acquired neuromyotonia patients without a change in human neuroblastoma cell line (NB-1). K ⍣ currents were suppressed in cells that had been co-cultured with gating kinetics. Our findings indicate that nerve hyperexcitability is mainly associated with the suppression acquired neuromyotonia patients' immunoglobulin for 3 days but not for 1 day. The activation and inactivation of voltage-gated K ⍣ currents with no change in gating kinetics, and that this suppression occurs not only in kinetics of the outward K ⍣ currents were not altered by these immunoglobulins, nor did the immunoglobulins acquired neuromyotonia but also in Guillain-Barré syndrome and idiopathic generalized myokymia without significantly affect the Na ⍣ currents. Myokymia or myokymic discharges, with peripheral nerve hyperpseudomyotonia.
Introduction
Acquired neuromyotonia (Isaacs' syndrome) is characterized described as an autoimmune disorder because anti-voltagegated K ϩ channel (VGKC) antibodies, which are closely by the presence of spontaneous and continuous muscle fibre activity (Isaacs et al., 1961) . Patients have characteristic associated with the pathomechanism of this disorder, are present in sera from acquired neuromyotonia patients whose symptoms of nerve hyperexcitability such as (i) pseudomyotonia (slow relaxation) induced by muscle contraction, (ii) symptoms respond to immunotherapy (Newsom-Davis et al., 1993; Shillito et al., 1995; Watanabe et al., 1995 ; Arimura increased cramping and (iii) excessive sweating (Kimura et al., 1983) . The abnormal activity in acquired neuromyet al., 1997; Hart et al., 1997) . Results of previous electrophysiological studies suggest that sera from these patients otonia is characterized electromyographically by doublet, triplet or single motor unit discharges that have a high suppress voltage-gated outward K ϩ currents in PC-12 cells (Sonoda et al., 1996) and induce repetitive firing of action intraburst frequency (40-200/s) (Newsom-Davis et al., 1993) . These discharges are thought to originate from terminal potentials in rat dorsal root ganglion cells (Shillito et al., 1995) . In terms of electrophysiology, the spontaneous firing arborizations of the motor axons (Newsom-Davis et al., 1993) . In recent reports, acquired neuromyotonia has been that originates in the peripheral nerves may be caused by VGKC inhibition and the stimulation of voltage-gated Na ϩ patient 2, a 44-year-old woman; patient 3, a 35-year-old man; channels; e.g. prolongation of the open time of the voltagepatient 4, an 18-year-old girl), two patients with Guillaingated Na ϩ channels in ciguatera intoxication (Cameron et al., Barré syndrome (patient 5, a 13-year-old girl; patient 6, 1991a, b; Gutmann et al., 1996) . We have studied previously a 31-year-old man) and two patients with IGM without the involvement of voltage-gated K ϩ currents in acquired pseudomyotonia (all IGM with the exception of acquired neuromyotonia patients (Sonoda et al., 1996) , but that of neuromyotonia: patient 7, a 43-year-old man; patient 8, a voltage-gated Na ϩ currents has not been investigated.
71-year-old man). The diagnosis of acquired neuromyotonia Symptoms of peripheral nerve hyperexcitability, such as was based on the clinical criteria reported by Kimura (1983) muscle cramp with spontaneous motor unit activities and [(i) pseudomyotonia (slow relaxation), (ii) increased cramping myokymic discharges, are characteristic not only of acquired and (iii) excessive sweating] and on the EMG criterion of neuromyotonia but of a wide range of peripheral neuropathies Newsom-Davis that it is characterized by doublet, triplet or (Auger et al., 1984; Jamieson et al., 1994) . Jamieson and multiplet single motor unit discharges that have a high colleagues defined idiopathic generalized myokymia (IGM) as (40-200/s) intraburst frequency (Newsom-Davis, 1993 ). a clinical syndrome accompanied by generalized continuous These abnormal discharges include myokymic and neuromotor unit activities or myokymia and having no apparent myotonic discharges defined by the AAEE (American Associaetiology (Jamieson et al., 1994) . IGM has been proposed ation of Electromyography and Electrodiagnosis) Glossary as the generic name for all disorders with continuous motor of terms in Clinical Electromyography. The diagnosis of unit activity, including acquired neuromyotonia and those IGM was based on the criteria of Jamieson (1994): clinical with muscle cramp and myokymia without the characsyndromes accompanied by generalized continuous motor teristic symptoms of acquired neuromyotonia (abnormal unit activities or myokymia and having no apparent aetiology. sweating, pseudomyotonia), e.g. myokymia-cramp syndrome
The patients' clinical features are given in Table 1 . Control (Jamieson et al., 1994) . Transient myokymic discharges also immunoglobulins were obtained from four healthy volunteers occur during the early stage of Guillain-Barré syndrome (a 27-and a 30-year-old woman and a 32-and a 55-year- (Mateer et al., 1983) . We found that serum from a Guillainold man), a patient with myasthenia gravis (a 70-year-old Barré syndrome patient suppressed the K ϩ currents in woman), a patient with Lambert-Eaton myasthenic syndrome PC-12 cells (Kurono et al., 1995) .
(LEMS) (a 61-year-old man) and a patient with chronic In the study reported here, we used the patch-clamp method inflammatory demyelinating polyradicuroneuropathy (CIDP) to answer the following questions. (i) Do immunoglobulins (a 48-year-old man). Informed consent was obtained from from acquired neuromyotonia patients affect K ϩ currents in all the patients and participants. a human neuroblastoma cell line (NB-1) which needs no
Immunoglobulins were isolated from the sera of patients neurotrophic factor for the expression of ion channels? Our and healthy participants by the 2-ethoxy-6,9 diaminoacridineprevious findings for the PC-12 cell line, which needs nerve lactate (acrinol) method. Each sample was mixed with 0.4% growth factor (NGF) for the expression of ion channels, did acrinol 1 : 5 then centrifuged at 20 000 g for 60 min at 4°C. not exclude possible effects of the patients' sera on the action
The supernatant was applied to a desalting column (HiTrap TM of NGF, which affects the expression of VGKCs. (ii) Do desalting column, Pharmacia Biotech, Uppsala, Sweden) preimmunoglobulins from patients with acquired neuromyotonia equilibrated with buffer (0.015 M sodium borate and 0.15 M affect Na ϩ currents? (iii) Do immunoglobulins from acquired NaCl, pH 8.5). The eluted solution was monitored in a neuromyotonia patients alter the kinetics of K ϩ currents? spectrophotometer at 280 nm, and the peak fractions were (iv) Do immunoglobulins from IGM without pseudomyotonia collected for further study. (all IGM with the exception of acquired neuromyotonia) and Guillain-Barré syndrome patients suppress K ϩ currents? (v) Do sera from acquired neuromyotonia patients affect the
Preparation of cells for recording
hKv (human voltage-gated K ϩ channel) 1 family expressed in NB-1 cells (Miyake et al., 1975) obtained from the Health CHO (Chinese hamster ovary)-K1 cells? Hart and colleagues Science Research Resources Bank (HSRRB, Osaka, Japan) detected autoantibodies to the hKv 1 family expressed in were cultured at 37°C in 95% air and 5% CO 2 in standard Xenopus oocytes in acquired neuromyotonia patients (Hart medium containing 80% MEM (Pharmacia Biotech, Uppsala, et al., 1997) . We therefore examined the electrophysiological Sweden), 10% FBS (foetal bovine serum), 10% horse serum, effects of patients' sera on hKv 1.1 and 1.6 expressed in 100 U/ml penicillin, 50 µg/ml streptomycin and 25 mM CHO-K1 cells. The answers to these questions should help HEPES (N-[2-hydroxyethyl]piperazine-NЈ-2-ethanesulphonic to clarify the pathomechanisms of disorders characterized by acid) (all from Gibco BRL, Rockville, Md, USA) on polyperipheral nerve hyperexcitability. L-lysine-coated 100 mm culture dishes (Iwaki, Funabashi, Japan). The medium was adjusted to pH 7.4 with NaOH and
Material and methods
changed every 2 or 3 days, and cells were passaged weekly.
To study the effect of the patients' immunoglobulins on the
Patients
electrical properties of NB-1, we cultured the cells with Immunoglobulins were obtained from four patients with acquired neuromyotonia (patient 1, an 82-year-old man;
5 µg/ml of the immunoglobulins from the patients or healthy 
ANM ϭ acquired neuromyotonia; GBS ϭ Guillain-Barré syndrome; IGM ϭ idiopathic generalized myokymia. The characteristic features of the neuromyotonic and myokymic discharges were defined according to the definition by American Association of Electromyography and Electrodiagnosis (AAEE) Glossary of Terms in Clinical Electromyography.
controls for 1 or 3 days. At concentrations ജ5 µg/ml square pulses (300 ms duration) between -140 and ϩ60 mV (20 mV step) were applied at 15 s intervals. Because the there were frequent signs of cell damage; therefore, this concentration was used in all experiments. All the experiments waveform of the elicited current in most NB-1 cells showed decay ( Fig. 2A ), the peak current and the steady-state current were performed at 32 Ϯ 2°C.
CHO-K1 cells from HSRRB were cultured at 37°C in (current at the end of the pulse) during the command pulse were both evaluated. Because the waveform of the elicited 95% air and 5% CO 2 in MEM Alpha medium (Nikken BioMedical Laboratory, Kyoto, Japan) supplemented with K ϩ current in transfected CHO-K1 cells showed scarcely any decay, only the peak current was evaluated. For Na ϩ 5% FBS, 5% horse serum, 100 U/ml penicillin and 25 mM HEPES, on 100 mm polystyrene dishes (Iwaki, Funabashi, current recording, NB-1 cells were held at the same holding potential, and square pulses (30 ms duration) between -100 Japan). cDNA (complementary DNA) for the VGKC α-subunit of human Kv 1.1 and 1. 6 (KCNA1 and KCNA6) and 0 mV (20 mV steps) were applied at the intervals used in the K ϩ current recording, after which the inward peak were prepared as reported by O. Pongs (Universität Hamburg) (Grupe et al., 1990) . Cells were split and plated at 2 ϫ 10 5 currents were evaluated. The linear leak current fraction was calculated by the least-squares method from currents obtained cells in 35 mm culture dishes 24 h before transfection, and transfected with plasmid DNA (2 µg/ml) encoding hKv 1.1 at test potentials of -100, -80 and -60 mV. The membrane capacitance (C m ) of each cell was calculated by measuring or 1.6 using DMRIE-C Reagent (Gibco BRL). Enhanced green fluorescent protein was coexpressed with the channel the charge transfer during the initial capacitative surge (Q) elicited by a 10 mV depolarizing pulse at the V hold of -80 subunits in order to identify the cells for voltage-clamp analysis. After 5-6 h of exposure, the cells were washed once mV, using the equation Q ϭ C m ϫ V. Taking into account that the membrane capacitance reflects the membrane area, then incubated for 3 days with growth medium containing 2% serum from the patients or controls. Whole-cell recordings the ion current was normalized using the equation: showed typical hKv 1.1 or 1.6 currents in 100% of the cells ion current density (pA/pF) ϭ expressing enhanced green fluorescent protein. Control cells (measured current -leak current)/C m (non-transfected or non-fluorescing cells) did not show these currents.
Statistics
The F test was used to examine whether the data had a
Patch-clamp recording
Ion current recordings were carried out as described previGaussian distribution. If the P value in the F test was Ͼ0.05 the data were analysed using Student's t test, otherwise a ously (Sonoda et al., 1996) . In K ϩ current recording, cells were held at the holding potential (V hold ) of -80 mV, and non-parametric test (the Mann-Whitney U test) was used. Cells were cultured for 3 days with immunoglobulins from the controls or patients. The test potential of the K ϩ current was ϩ40 mV and that of the Na ϩ current -20 mV from the holding potential of -80 mV. The numbers of cells are shown in parentheses. Ion current density (pA/pF) ϭ (measured current -leak current)/C m . MG ϭ myasthenia gravis. *P Ͻ 0.05, **P Ͻ 0.01. Values are given as mean Ϯ standard error unless otherwise reversal potential at ϩ40 mV. Figure 1B (insert) shows a specified.
typical example of the K ϩ current elicited by a 300 ms depolarizing pulse of ϩ40 mV from the holding potential of -80 mV in a cell cultured under the above conditions.
Results
The outward current occurred with decay. No outward current was detected when a K ϩ -free internal solution was used,
Effects of immunoglobulins from acquired
evidence that the outward current was a K ϩ current. The neuromyotonia patients on K ⍣ currents and current-voltage relationship for the K ϩ current is shown in Na ⍣ currents Fig. 1B for test voltages from -140 to ϩ60 mV from the When NB-1 cells were cultured for 2-3 days, two types of holding potential of -80 mV. The continuous line is fitted cells, blast and mature cells, were present. The shape of the for the measured peak currents and the broken line for the typical blast type cell is a teardrop with two short, thick measured steady-state currents (currents at the end of the processes at each end, whereas the mature cell is round with pulse). The current was activated at -30 mV and more several long processes. We used the blast type for the positive potentials. At 40 mV it was 2451 pA for the peak patch-clamp experiments because it was better suited to and 1309 pA for the steady state; therefore, 47% inactivation space-clamping. To examine the effects of immunoglobulins occurred within 300 ms at this test potential. Na ϩ and K ϩ from patients with acquired neuromyotonia on the electrical currents were present in all the blast-type cells examined properties of NB-1 cells, the cells were cultured with the (n ϭ 168). immunoglobulins for 3 days. Resting membrane potentials
The effects of immunoglobulins from the acquired neurowere -46 to -55 mV, and they were not significantly different myotonia patients on the K ϩ and Na ϩ currents were examined. from those of cells cultured with the control immunoglobulins Figure 2A shows typical K ϩ currents elicited by 300 ms test (-53 mV). Cell capacitances were 46-52 pF, again not pulses between -140 and ϩ60 mV from the holding potential significantly different from the control cell value of 47 pF of -80 mV in a cell cultured with immunoglobulin from a ( Table 2) . healthy control. Outward rectifying currents with decay were Figure 1A (insert) shows a typical example of the Na ϩ present at potentials more positive than -20 mV. With the current elicited by a 30 ms depolarizing pulse of -20 mV control immunoglobulin, the peak K ϩ current density at the from the holding potential of -80 mV in an NB-1 cell ϩ40 mV test potential was 48.1 pA/pF and the steady-state cultured in medium containing 5 µg/ml of the control current density was 23.4 pA/pF. Figure 2C shows K ϩ currents immunoglobulin. A transient inward current, elicited just in another cell cultured under the same conditions with the after the positive capacitative current, was abolished when immunoglobulin from patient 1. The respective peak and the external solution was changed to Na ϩ -free solution, and steady-state current densities were 6.03 and 2.88 pA/pF at was suppressed by 90% by 10 µM tetrodotoxin, indicating ϩ40 mV. Thus, the K ϩ currents in cells cultured with the that the inward current was a Na ϩ current. The currentpatient's immunoglobulin were considerably less than those voltage relationship of the Na ϩ current in the same cell in cells cultured with the control immunoglobulin. Similar elicited by test voltages of -100 to ϩ60 mV is shown in results were obtained for the immunoglobulins from the other Fig. 1A . The Na ϩ current appeared at about -50 mV, the maximum peak current (-1716 pA) at -20 mV and the patients with acquired neuromyotonia (patients 2-4). Typical Fig. 2 The K ϩ current elicited in NB-1 cells by 300 ms test pulses from -140 to ϩ60 mV from the holding potential of -80 mV. Cells were cultured for 3 days with 5 µg/ml of immunoglobulins from a control (A) and patient 1 with acquired neuromyotonia (C). Na ϩ current was elicited by 30 ms test pulses from -100 to 0 mV from the holding potential of -80 mV under the same conditions from a control (B) and patient 1 (D).
Na ϩ currents are shown in Fig. 2B (with 5 µg/ml control immunoglobulins. In addition, the peak current densities were suppressed more effectively than the steady-state current immunoglobulin) and Fig. 2D (with 5 µg/ml immunoglobulin from patient 1). Cells were held at -80 mV and test pulses densities. Figure 3C shows the average Na ϩ current densities at the test potential of -20 mV (data shown as absolute from -100 to 0 mV were applied for 30 ms. At the test potential of -20 mV, the inward peak Na ϩ current density values). The mean Na ϩ current density in cells cultured with the control immunoglobulins was 32.3 Ϯ 3.1 pA/pF was -39.9 pA/pF in the NB-1 cell cultured with the control immunoglobulin and -36.8 pA/pF in the cell cultured with (n ϭ 43). The Na ϩ currents in cells cultured with the patients' immunoglobulins did not differ significantly from those in the patient's immunoglobulin. There was no apparent change in Na ϩ current in the NB-1 cells cultured with these two cells cultured with the control immunoglobulins, except in the case of patient 3. immunoglobulins. Figure 3A and B give the averages of the K ϩ current To exclude non-specific effects of the immunoglobulins, we tested those from patients with myasthenia gravis, LEMS densities measured at the test potential of ϩ40 mV in cells cultured for 3 days with the immunoglobulins from the four and CIDP as the disease controls. The K ϩ and Na ϩ current densities in NB-1 cells cultured with these immunoglobulins healthy control subjects or immunoglobulins from patients with acquired neuromyotonia (patients 1-4), Guillain-Barré did not differ from those for cells cultured with immunoglobulins from the healthy controls ( Fig. 3 and Table 2 ). syndrome (patients 5 and 6) and IGM without pseudomyotonia (patients 7 and 8) and patients with other neurological
We also examined subacute effects on the K ϩ and Na ϩ currents of NB-1 cells cultured for 1 day with diseases (myasthenia gravis, LEMS and CIDP). The averages of the K ϩ current densities for the control immunoglobulins immunoglobulins from the healthy controls and patient 1.
The calculated K ϩ current densities for the controls (n ϭ were 20.0 Ϯ 1.9 pA/pF (n ϭ 40) for the steady state and 40.1 Ϯ 2.8 pA/pF (n ϭ 40) for the peak (Table 2) . Although 25) were 18.4 Ϯ 2.0 pA/pF for the steady state and 43.6 Ϯ 3.9 pA/pF for the peak current. In cells cultured the K ϩ current amplitude had a large degree of variability within the same treatment group, both the peak and steadywith immunoglobulin from patient 1, the steady-state current density was 19.9 Ϯ 3.0 pA/pF and the peak current state K ϩ current densities were suppressed in NB-1 cells cultured with immunoglobulins from the acquired neuromydensity 50.4 Ϯ 4.9 pA/pF (n ϭ 10). There was no significant difference between the K ϩ current densities in otonia patients compared with cells cultured with the control pA/pF (n ϭ 9, patient 1) indicated that there was no significant change in the Na ϩ currents (data not shown). Activation of the peak K ϩ current was determined by were cultured for 3 days with 5 µg/ml of the immunoglobulins calculating the peak K ϩ conductance from the linear conductfrom the patients and controls. Steady state K ϩ (A) and peak K ϩ (B) current densities were obtained at the test potential of ϩ40 ance equation:
, where G K is the conductmV from the holding potential of -80 mV, and Na ϩ current ance, I K the K ϩ current, V t the test potential and E K the K ϩ densities (absolute values) at the test potential of -20 mV from equilibrium potential. The E K value was assumed to be -84 the same holding potential (C). Bars show the mean current mV in this experimental condition. Figure 4A shows the density Ϯ standard error. *P Ͻ 0.05, **P Ͻ 0.01, compared with activation curves of the peak K ϩ currents in NB-1 cells four healthy controls. cultured for 3 days with immunoglobulins from the controls (n ϭ 11), patient 1 (n ϭ 5) and patient 2 (n ϭ 5). The cells cultured with the immunoglobulins from patients and those from controls. The respective Na ϩ current densities smooth curves are the least-squares fitted lines for the relative K ϩ conductances. The average values of the potential at of 32.4 Ϯ 4.2 pA/pF (n ϭ 25, control) and 33.2 Ϯ 6.6 which the relative G K was 0.5 (V 1/2 ) were 9.83 mV (control), patient 1, 28.4 Ϯ 7.7; patient 2, 32.7 Ϯ 6.1 pA/pF). In Fig. 5C , the V 1/2 values were -17.36 (control), -16.94 (patient 6.73 mV (patient 1) and 7.43 mV (patient 2), showing very little difference among them. The average values of the slope 1) and -19.31 mV (patient 2). The slope factors (k) were -11.53 (control), -12.28 (patient 1) and -12.71 (patient 2). factor (k) were -12.49 (control), -15.22 (patient 1) and -13.81 (patient 2), again showing very little difference.
In Fig. 5D , the V 1/2 values were -14.32 (control), -12.68 (patient 1) and -10.45 mV (patient 2), and the respective k Figure 4B shows the inactivation of the peak K ϩ current at the test potential of ϩ40 mV, which was examined by altering values were -10.37, -11.78 and -12.24. We conclude that the K ϩ currents were suppressed significantly by the acquired the holding potential for the controls (n ϭ 15), patient 1 (n ϭ 5) and patient 2 (n ϭ 6). The V 1/2 averages were neuromyotonia patients' sera in CHO-K1 cells transfected with hKv 1.1 or 1.6, whereas there was almost no difference -15.40 mV (control), -16.39 mV (patient 1) and -20.54 mV (patient 2). The average k values were 9.09 (patient 1), 7.88 in the activation curves. (patient 2) and 7.85 (patient 2). In addition, the respective V 1/2 averages of the inactivation curves for cells cultured for 6 days with immunoglobulins from the control and patient 1
Discussion
The pathomechanism of nerve hyperexcitability in acquired were -18.27 and -18.30 mV, and the average k values were 5.81 and 4.75 (figure not shown). We therefore concluded neuromyotonia is closely correlated with anti-VGKC antibodies (Sinha et al., 1991; Shillito et al., 1995; Sonoda et al. , that the voltage-dependence for activation and inactivation did not differ significantly between cells cultured with the 1996; Arimura et al., 1997; Hart et al., 1997) . We showed that sera from acquired neuromyotonia patients suppressed control or patients' immunoglobulins.
K ϩ currents in a PC-12 cell line (Kurono et al., 1995; Sonoda et al., 1996) . Because this cell line requires NGF for the expression of VGKCs (Sonoda et al., 1996) , the involvement
Effects of immunoglobulins from
of NGF in K ϩ current suppression could not be ruled out.
Guillain-Barré syndrome and IGM patients on
In the study reported here, we used an NB-1 cell line (Miyake K ⍣ currents and Na ⍣ currents et al., 1975) that does not require a neurotrophic factor such Effects on K ϩ and Na ϩ currents in NB-1 cells co-cultured as NGF for the expression of ion channels. Furthermore, for 3 days with immunoglobulins from patients with Guillainour previous experimental findings using 4-aminopyridine, Barré syndrome and IGM without pseudomyotonia were tetraethylammonium and tetrodotoxin confirmed the existence studied. The resting membrane potential and cell capacitance of voltage-gated K ϩ currents and voltage-gated Na ϩ currents did not differ from the control values (Table 2 ). Figure 3A in NB-1 cells (Y. Horikiri, unpublished observation). The and B shows the K ϩ current densities measured in cells present findings confirm the suppression of voltage-gated K ϩ cultured with 5 µg/ml of the immunoglobulins from patients currents in NB-1 cells by immunoglobulins from acquired 5-8. The steady-state current and the peak K ϩ currents were neuromyotonia patients, indicating that NGF is not involved both suppressed, but the suppression was greater for the peak in the inhibition of K ϩ currents. K ϩ currents. The Na ϩ currents in cells cultured with the Our findings also showed that K ϩ currents were suppressed patients' immunoglobulins did not differ significantly from only in cells co-cultured with the immunoglobulins from those of the controls (Fig. 3C) . The effects of the immunoacquired neuromyotonia patients for 3 days, but not in those globulins from the patients with Guillain-Barré syndrome cultured for 1 day. A similar phenomenon was noted in our and IGM without pseudomyotonia on both the K ϩ and Na ϩ previous study of a PC-12 cell line (Sonoda et al., 1996) . currents were similar to those of immunoglobulins from Moreover, the voltage-dependence of the activation and patients with acquired neuromyotonia.
inactivation of the K ϩ current did not differ between cells cultured with the control and patients' immunoglobulins, indicating that antibodies to VGKC may not directly suppress Effects of sera from acquired neuromyotonia its functions or change its kinetics. Interestingly, Meriney and colleagues reported similar finding in the suppression of patients on expressed hKv 1.1 and 1.6 Figure 5A and B shows the averages of the peak K ϩ current Ca 2ϩ channels by a LEMS IgG (Meriney et al., 1996) . They found that the LEMS immunoglobulin required 24 h for densities measured at the test potential of ϩ40 mV in each transfected cell type cultured for 3 days with sera from two maximal effect and proposed that this is consistent with the process of Ca 2ϩ channel removal reaching equilibrium with healthy participants (controls 1 and 2) and two acquired neuromyotonia patients (patients 1 and 2). Figure 5C and D the insertion of new Ca 2ϩ channels in the plasma membrane. Taken together, these findings suggest that decreasing VGKC shows the activation curves of the K ϩ currents in these cells. The cells in Fig. 5A and C were transfected with hKv 1.1, expression or increasing VGKC degradation through some type of intracellular signalling pathway may be involved in and those in Fig. 5B and D with hKv 1.6. The K ϩ currents were suppressed significantly by the patients' sera, as shown the reduction of outward K ϩ current. Nerve hyperexcitability, which is also seen in myokymia, in Fig. 5A (control, 23.3 Ϯ 2.0; patient 1, 12.2 Ϯ 1.7; patient 2, 10.9 Ϯ 2.6 pA/pF) and Fig. 5B (control, 72.0 Ϯ 8.7 ; is present in both VGKC downregulation and the prolonged activation of voltage-gated Na ϩ channels (Cameron et al., currents is an important step in establishing the aetiology of nerve hyperexcitability, and that acquired neuromyotonia 1991a, b; Gutmann et al., 1996) . We showed that immunoglobulins from patients with acquired neuromyotonia do not and IGM without pseudomyotonia (IGM except acquired neuromyotonia) may belong to the same disease spectrum, affect Na ϩ currents, which is evidence that these currents do not function in the pathomechanism of this disease.
the former being the more severe. In our findings, immunoglobulins from patients with GuilMyokymia and muscle cramp caused by nerve hyperexcitability are found in a variety of diseases of unknown aetiology lain-Barré syndrome suppressed K ϩ currents but not Na ϩ currents in NB-1 cells. We did not perform an electromyo- (Auger et al., 1984; Jamieson et al., 1994) . Our patients 7 and 8 had IGM that was characterized by clinical myokymia graphic study on our Guillain-Barré syndrome patients, and only one patient had muscle cramp. In the early stage of or muscle cramp with myokymic discharges of unknown aetiology (Auger et al., 1984; Jamieson et al., 1994) . Because Guillain-Barré syndrome, myokymic discharges are occasionally and transiently detectable by electromyography the pseudomyotonia and hypersweating that are characteristic of acquired neuromyotonia were absent in these patients (Mateer et al., 1983) , and suppression of K ϩ currents may be the pathomechanism of these discharges in Guillain-Barré (Table 1) , we classified them as patients with IGM but without pseudomyotonia (IGM with the exception of acquired syndrome.
Western blots showed that NB-1 cells, which we used, neuromyotonia). The immunoglobulins of these two patients suppressed outward K ϩ currents but did not markedly affect have hKv 1.1 and 1.2 but not 1.6 (O. Pongs, unpublished data).
Hart and colleagues, in their molecular immunohistochemical Na ϩ currents, as was also the case for the immunoglobulins of patients with acquired neuromyotonia. These results sugassay of Xenopus oocytes transfected with the cDNA of human brain VGKCs (KCNA1, KCNA2 and KCNA6), congest that the suppression of K ϩ currents, which may induce nerve hyperexcitability, is not specific to acquired neuromyfirmed that all these VGKCs are involved in the pathomechanism of acquired neuromyotonia (Hart et al., 1997) . They also otonia, and that the underlying electrophysiological abnormalities between myokymic discharges and neuromyotonic showed that acquired neuromyotonia sera vary widely in immunoreactivity to the three VGKCs studied and suggested discharges may represent merely a continuum or spectrum of the same phenomenon.
that the anti-VGKC antibodies in acquired neuromyotonia may be heterogeneous in their fine specificities, binding not We believe that the investigation of the suppression of K ϩ
